The safety of lumiracoxib when used in the treatment of arthritis

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.2, 2005-02, pp. : 347-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GI and cardiovascular safety of lumiracoxib on TARGET

Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Lumiracoxib

By Katherine A. Lyseng-Williamson Monique P. Curran

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2237-2246

Adis International

Access to resources Recommend Favorite

Global Gastrointestinal Safety Profile of Etoricoxib and Lumiracoxib

Current Pharmaceutical Design, Vol. 13, Iss. 22, 2007-08 ,pp. : 2237-2247

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

By Poddubnyy Denis Rudwaleit Martin

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 655-673

Informa Healthcare

Access to resources Recommend Favorite

Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder

By Oefelein Michael G.

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 733-754

Adis International

Access to resources Recommend Favorite